Evidence map›Paper›PMID 40792423›Full record

ArticleCancer medicine2025

Super-Resolution Ultrasound Radiomics Can Predict the Upstaging of Ductal Carcinoma In Situ.

Liang Yang, Xiaoxian Li, Zhiyuan Wang, Qian Li, Juan Fu, Xuebin Zou, Xia Liang, Xu Liu, Ruirui Zhang, Junjun Chen and 3 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Liang YangDepartment of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
Xiaoxian LiDepartment of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
Zhiyuan WangDepartment of Medical Ultrasound, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
Qian LiDepartment of Ultrasound, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China.
Juan FuDepartment of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
Xuebin ZouDepartment of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
Xia LiangDepartment of Medical Ultrasound, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
Xu LiuDepartment of Medical Ultrasound, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
Ruirui ZhangDepartment of Ultrasound, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China.
Junjun ChenDepartment of Ultrasound, Dongguan People's Hospital Affiliated to Southern Medical University, Dongguan, Guangdong, China.
Hui XieDepartment of Radiation Oncology, Affiliated Hospital (Clinical College) of Xiangnan University, Chenzhou, Hunan, People's Republic of China.
Yini HuangDepartment of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.
Jianhua ZhouDepartment of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.ORCID https://orcid.org/0000-0003-2096-8126

Funding

National Natural Science Foundation of China 82320108011Natural Science Foundation of Guangdong Province 2023A1515011564
6 · The paper itself

Abstract

introductionPreoperatively distinguishing pure ductal carcinoma in situ (DCIS) from upstaged DCIS is important for deciding optimal surgical strategies. However, it is hard to preoperatively predict the upstaging of biopsy-proven DCIS. This study aims to develop an effective radiomics model for predicting the upstaging of DCIS based on super-resolution (SR) ultrasound images.

methodsIn this multicentre retrospective study, patients with biopsy-proven DCIS who underwent ultrasound examination were included. A super-resolution reconstruction algorithm was used to enhance the resolution of original high resolution (HR) ultrasound images and obtain SR images. Pyradiomics was used for feature extraction. The selected HR radiomics features and SR radiomics features were combined with clinical features to construct the HR fusion model and SR fusion model, respectively. The area under the receiver operating characteristic curve (AUC) of the models and radiologists was analyzed and compared by the Delong test.

resultsA total of 681 women (median age, 47 years; interquartile range, 42-54) with 681 biopsy-proven DCIS lesions were included, with 422 lesions in the training set, 106 lesions in the validation set, and 153 lesions in the external test set. The SR Fusion model achieved an AUC of 0.819 (0.732-0.887) in the validation set and 0.800 (95% CI 0.728-0.860) in the external test set. It outperformed the radiologists (AUC = 0.603-0.627; p < 0.001) in the validation set. Additionally, it surpassed the clinical model (AUC = 0.682, 95% CI 0.602-0.755; p = 0.02) and the HR Fusion model (AUC = 0.724, 95% CI 0.646-0.793; p = 0.03) in the external test set.

conclusionThe SR Fusion model integrating SR features and clinical features can effectively predict the upstaging of DCIS.

Indexed as

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingUltrasonography, MammaryAdultFemaleHumansMiddle AgedNeoplasm StagingRadiomicsRetrospective StudiesROC Curvebreast cancerductal carcinoma in situmachine learningsuper‐resolution reconstructionultrasound

Identifiers

PMID40792423
PMCPMC12340541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.